Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/10/2025 ,inter alia, to consider and approve The unaudited financial results (standalone) of the Company for the quarter and half year ended 30th September 2025.